{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:31:26Z","timestamp":1793745086869,"version":"4.6.1"},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>Hematopoietic stem cell transplantation is a life-saving therapy for many patients with cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic anemia, sickle cell disease, and certain congenital immune deficiencies. Kidney injury directly associated with stem cell transplantation includes a wide range of structural and functional abnormalities, which may be vascular (hypertension, thrombotic microangiopathy), glomerular (albuminuria, nephrotic glomerulopathies), and\/or tubulointerstitial. AKI occurs commonly after stem cell transplant, affecting 10%\u201373% of patients. The cause is often multifactorial and can include sepsis, nephrotoxic medications, marrow infusion syndrome, hepatic sinusoidal obstruction syndrome, thrombotic microangiopathy, infections, and graft versus host disease. The risk of post-transplant kidney injury varies depending on patient characteristics, type of transplant (allogeneic versus autologous), and choice of chemotherapeutic conditioning regimen (myeloablative versus nonmyeloablative). Importantly, AKI is associated with substantial morbidity, including the need for KRT in approximately 5% of patients and the development of CKD in up to 60% of transplant recipients. AKI has been associated universally with higher all-cause and nonrelapse mortality regardless of transplant type, and studies have consistently shown extremely high (&gt;80%) mortality rates in those patients requiring acute dialysis. Accordingly, prevention, early recognition, and prompt treatment of kidney injury are essential to improving kidney and patient outcomes after hematopoietic stem cell transplantation, and for realizing the full potential of this therapy.<\/jats:p>","DOI":"10.2215\/cjn.08580719","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T15:35:19Z","timestamp":1576251319000},"page":"289-297","source":"Crossref","is-referenced-by-count":98,"title":["Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation"],"prefix":"10.2215","volume":"15","author":[{"given":"Amanda DeMauro","family":"Renaghan","sequence":"first","affiliation":[{"name":"Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"Jaimes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Renal Service, Memorial Sloan Kettering Cancer Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Malyszko","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut;"},{"name":"Veterans Affairs Medical Center, West Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sprangers","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Laboratory of Molecular Immunology, Rega Institute, KU Leuven, Belgium; and"},{"name":"Division of Nephrology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell Howard","family":"Rosner","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5000055","article-title":"Acute renal failure in hematopoietic cell transplantation","volume":"69","author":"Parikh","year":"2006","journal-title":"Kidney Int"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1523-1755.2005.00078.x","article-title":"Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors","volume":"67","author":"Hingorani","year":"2005","journal-title":"Kidney Int"},{"key":"B4-20230813","first-page":"500","article-title":"Acute kidney injury in patients with cancer","volume":"377","author":"Rosner","year":"2017","journal-title":"N Engl J Med"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: One size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMra1404711","article-title":"Renal complications of hematopoietic-cell transplantation","volume":"374","author":"Hingorani","year":"2016","journal-title":"N Engl J Med"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0272-6386(89)80054-X","article-title":"Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients","volume":"13","author":"Zager","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1523-1755.2002.00455.x","article-title":"Renal dysfunction in allogeneic hematopoietic cell transplantation","volume":"62","author":"Parikh","year":"2002","journal-title":"Kidney Int"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2004.11.013","article-title":"Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation","volume":"45","author":"Parikh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ki.1996.405","article-title":"Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer","volume":"50","author":"Merouani","year":"1996","journal-title":"Kidney Int"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1046\/j.1523-1755.2003.00936.x","article-title":"Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis","volume":"63","author":"Fadia","year":"2003","journal-title":"Kidney Int"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/bmt.2014.100","article-title":"Acute kidney injury in critically ill allo-HSCT recipients","volume":"49","author":"Canet","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bmt.1705513","article-title":"Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation","volume":"38","author":"Lopes","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bmt.2009.377","article-title":"A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT","volume":"45","author":"Ando","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbmt.2007.12.492","article-title":"Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation","volume":"14","author":"Parikh","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/bmt.2015.188","article-title":"Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients","volume":"50","author":"Shingai","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1523-1755.2005.00301.x","article-title":"Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant","volume":"67","author":"Parikh","year":"2005","journal-title":"Kidney Int"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000168889","article-title":"Acute renal failure in patients following bone marrow transplantation: Prevalence, risk factors and outcome","volume":"15","author":"Gruss","year":"1995","journal-title":"Am J Nephrol"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/01.ASN.0000129981.50357.1C","article-title":"Acute renal failure after nonmyeloablative hematopoietic cell transplantation","volume":"15","author":"Parikh","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bmt.2009.99","article-title":"A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT","volume":"45","author":"Liu","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbmt.2008.10.011","article-title":"Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience","volume":"15","author":"Pi\u00f1ana","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2014.05.022","article-title":"Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes","volume":"20","author":"Chang","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/bmt.2009.363","article-title":"Engraftment syndrome after auto-SCT: Analysis of diagnostic criteria and risk factors in a large series from a single center","volume":"45","author":"Carreras","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2215\/CJN.10630917","article-title":"Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: A prospective cohort study","volume":"13","author":"Hingorani","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bmt.1705412","article-title":"Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation","volume":"38","author":"Caliskan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.semnephrol.2010.09.009","article-title":"Acute kidney injury in hematopoietic cell transplantation","volume":"30","author":"Kogon","year":"2010","journal-title":"Semin Nephrol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis","volume":"351","author":"Schrier","year":"2004","journal-title":"N Engl J Med"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2013.08.007","article-title":"The kidney effects of hematopoietic stem cell transplantation","volume":"21","author":"Sawinski","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ctrv.2009.11.001","article-title":"An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome","volume":"36","author":"Mughal","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1093\/ndt\/gfp330","article-title":"A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome","volume":"24","author":"Shimada","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","article-title":"Crystal-induced acute renal failure","volume":"106","author":"Perazella","year":"1999","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"B34-20230813","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/49.suppl_1.81","article-title":"Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients","volume":"49","author":"Cagnoni","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"e22166","DOI":"10.1002\/jbt.22166","article-title":"Oxidative stress-induced renal telomere shortening as a mechanism of cyclosporine-induced nephrotoxicity","volume":"32","author":"Raeisi","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2018.06.013","article-title":"Emerging concepts in hematopoietic stem cell transplantation-associated renal thrombotic microangiopathy and prospects for new treatments","volume":"72","author":"Wanchoo","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/TP.0000000000000961","article-title":"Calcineurin-inhibition results in upregulation of local renin and subsequent vascular endothelial growth factor production in renal collecting ducts","volume":"100","author":"Pr\u00f3kai","year":"2016","journal-title":"Transplantation"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ki.1994.417","article-title":"Acute renal failure in the setting of bone marrow transplantation","volume":"46","author":"Zager","year":"1994","journal-title":"Kidney Int"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: Role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/bmt.2008.7","article-title":"Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: Defining a disorder","volume":"41","author":"George","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","article-title":"Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kojouri","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of the Late Effects Working Party of the European group for blood and marrow transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bmt.1701151","article-title":"Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy","volume":"21","author":"Kanamori","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1703026","article-title":"Serum levels of soluble adhesion molecules in stem cell transplantation-related complications","volume":"27","author":"Matsuda","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"B51-20230813","first-page":"4483","article-title":"Transplant associated thrombotic microangiopathy (TA-TMA) commonly occurs after steroid-refractory or dependent gastrointestinal (GI) graft versus host disease (GVHD) and contributes to post-transplant morbidity","volume":"130","author":"Wall","year":"2017","journal-title":"Blood"},{"key":"B52-20230813","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B53-20230813","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"B54-20230813","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"B55-20230813","first-page":"355","article-title":"Nephrotic syndrome after hematopoietic stem cell transplantation: A single center experience","volume":"106","author":"Beyar Katz","year":"2015","journal-title":"Minerva Med"},{"key":"B56-20230813","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1705446","article-title":"Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"38","author":"Reddy","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B57-20230813","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.2005.05728.x","article-title":"Nephrotic syndrome: An under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation","volume":"131","author":"Srinivasan","year":"2005","journal-title":"Br J Haematol"},{"key":"B58-20230813","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: Do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B59-20230813","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbmt.2015.12.014","article-title":"Adult nephrotic syndrome after hematopoietic stem cell transplantation: Renal pathology is the best predictor of response to therapy","volume":"22","author":"Beyar-Katz","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B60-20230813","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MAJ.0b013e318267b5cd","article-title":"Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy","volume":"346","author":"Huang","year":"2013","journal-title":"Am J Med Sci"},{"key":"B61-20230813","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5414\/CNP67005","article-title":"Favorable long-term outcome of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Kemper","year":"2007","journal-title":"Clin Nephrol"},{"key":"B62-20230813","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"B63-20230813","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0046-8177(91)90104-W","article-title":"Necrotizing tubulointerstitial nephritis associated with adenovirus infection","volume":"22","author":"Ito","year":"1991","journal-title":"Hum Pathol"},{"key":"B64-20230813","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1016\/j.transproceed.2010.08.049","article-title":"Hematuria due to adenoviral infection in bone marrow transplant recipients","volume":"42","author":"Bil-Lula","year":"2010","journal-title":"Transplant Proc"},{"key":"B65-20230813","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41409-018-0428-6","article-title":"A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation","volume":"54","author":"Benoit","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B66-20230813","article-title":"Early diagnostic markers for detection of acute kidney injury in allogeneic hematopoietic stem cell transplant recipients","author":"Deger","journal-title":"Exp Clin Transplant"},{"key":"B67-20230813","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3109\/0886022X.2015.1040699","article-title":"Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients","volume":"37","author":"Taghizadeh-Ghehi","year":"2015","journal-title":"Ren Fail"},{"key":"B68-20230813","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.bbmt.2014.08.022","article-title":"Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation","volume":"20","author":"Shingai","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B70-20230813","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/clpt.2009.27","article-title":"Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: A phase II trial in patients with hematologic malignancy","volume":"85","author":"McCune","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"B71-20230813","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00467-007-0672-2","article-title":"Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group","volume":"23","author":"Flores","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B72-20230813","first-page":"619","article-title":"Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury","volume":"60","author":"Zager","year":"1989","journal-title":"Lab Invest"},{"key":"B73-20230813","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V24848","article-title":"The influence of mannitol on myoglobinuric acute renal failure: Functional, biochemical, and morphological assessments","volume":"2","author":"Zager","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"B74-20230813","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br J Haematol"},{"key":"B75-20230813","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: Current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B76-20230813","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbmt.2018.02.015","article-title":"Defibrotide for sinusoidal obstruction syndrome\/veno-occlusive disease prophylaxis in high-risk adult patients: A single-center experience study","volume":"24","author":"Picod","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B77-20230813","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B78-20230813","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"key":"B79-20230813","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/trf.13437","article-title":"Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"56","author":"Fujiwara","year":"2016","journal-title":"Transfusion"},{"key":"B80-20230813","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"B81-20230813","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/1744-9987.12015","article-title":"Plasmapheresis-refractory transplantation-associated thrombotic microangiopathy successfully treated with pravastatin and limaprost alfadex","volume":"17","author":"Uesawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"B82-20230813","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B83-20230813","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B84-20230813","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/bloodadvances.2016002832","article-title":"Use of the complement inhibitor Coversin to treat HSCT-associated TMA","volume":"1","author":"Goodship","year":"2017","journal-title":"Blood Adv"},{"key":"B86-20230813","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/ndt\/gfh720","article-title":"Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation","volume":"20","author":"Schrier","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"B87-20230813","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"B88-20230813","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbmt.2009.05.006","article-title":"Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation","volume":"15","author":"de Souza","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B89-20230813","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2008.08.015","article-title":"Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction","volume":"14","author":"Kersting","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B90-20230813","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis, and treatment","volume":"17","author":"Hingorani","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B91-20230813","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2006.02.021","article-title":"Renal dysfunction after total body irradiation: Dose-effect relationship","volume":"65","author":"Kal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B92-20230813","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: A systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"key":"B93-20230813","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","article-title":"Significant increase in end-stage renal disease after hematopoietic stem cell transplantation","volume":"39","author":"Cohen","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B94-20230813","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ndt\/gfp485","article-title":"Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: Prevalence and risk factors","volume":"25","author":"Ando","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B95-20230813","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/bmt.2012.85","article-title":"The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT","volume":"48","author":"Shimoi","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B96-20230813","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.ajkd.2012.09.020","article-title":"Kidney complications of hematopoietic stem cell transplantation","volume":"61","author":"Singh","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B97-20230813","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/1097-0142(19910601)67:11<2795::AID-CNCR2820671114>3.0.CO;2-D","article-title":"Late renal dysfunction in adult survivors of bone marrow transplantation","volume":"67","author":"Lawton","year":"1991","journal-title":"Cancer"},{"key":"B98-20230813","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V661661","article-title":"Evaluation of renal function in 60 long-term survivors of bone marrow transplantation","volume":"6","author":"Leblond","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"B99-20230813","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0360-3016(02)03039-0","article-title":"Renal toxicity after total body irradiation","volume":"54","author":"Borg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B100-20230813","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2004100843","article-title":"Renal failure associated with cancer and its treatment: An update","volume":"16","author":"Humphreys","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B101-20230813","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000188587","article-title":"Bone marrow transplant nephropathy: Radiation nephritis revisited","volume":"70","author":"Cohen","year":"1995","journal-title":"Nephron"},{"key":"B102-20230813","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbmt.2008.09.015","article-title":"Albuminuria in hematopoietic cell transplantation patients: Prevalence, clinical associations, and impact on survival","volume":"14","author":"Hingorani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B103-20230813","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000450798","article-title":"Emergence of dipstick proteinuria predicts overt nephropathy in patients following stem cell transplantation","volume":"135","author":"Momoki","year":"2017","journal-title":"Nephron"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.08580719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:24Z","timestamp":1786369164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.08580719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08580719","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]}}}